Next-Generation Sequencing - Global Forecasts to 2021

Sharon White

Description

This report provided by GrandResearchStore is about,The global NGS market is expected to reach USD 10,371.1 million by 2021 from USD 4,031.7 million in 2016, at a CAGR of 20.8% between 2016 and 2021. North America is expected to hold the largest share of the global NGS market in 2016. The NGS market is broadly segmented into products & services, technology, application, and end user. By products & services, the NGS market is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics. The consumables segment is expected to command the major share of the NGS market, by products& services, in 2016.

Informations

• Publié par: sharonw
• Publié le: 13 janvier 2017
• Nombre de lectures: 1
• Langue: English

Extrait

Next-Generation Sequencing (NGS) Market by Platforms
(HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton,
PGM, IonS5, PacBio & Sequel), Services (Targeted
Sequencing, De novo), & Application (Diagnostic, Drug
Discovery) - Global Forecasts to 2021
Published On : March 2016
Category : Medical Devices
Pages : 209 pages
Contact : International : ([phone] [e-mail]
Report Description:
The global NGS market is expected to reach USD 10,371.1 million by 2021 from USD
4,031.7 million in 2016, at a CAGR of 20.8% between 2016 and 2021. North America is
expected to hold the largest share of the global NGS market in 2016. The NGS market is
broadly segmented into products & services, technology, application, and end user. By
products & services, the NGS market is segmented into pre-sequencing products &
services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics.
The consumables segment is expected to command the major share of the NGS market, by
products& services, in 2016.
Geographically, the report covers four major geographies, namely, North America, Europe,
Asia-Pacific, and the Rest of the World. North America is expected to command the largest
share of the global NGS market in 2016, followed by Europe. Asia-Pacific NGS market is
poised to witness highest growth rate during the forecast period from 2016 to 2021 due to a
number of factors including improving healthcare infrastructure and favorable government
initiatives.Market growth is majorly driven by the technological advancements in NGS products,
increasing applications of NGS, entry of new market players, increasing partnerships &
collaborations among market players, and growing incidences of cancer, inherited rare
disorders, and pre- and neo-natal disorders.
As of 2015, the global NGS market was dominated by Illumina, Inc. (U.S.); Thermo Fisher
Scientific, Inc. (U.S.); and Pacific Biosciences of California, Inc. (U.S.) which together held a
share of 94% of the overall NGS platforms market. New product launches & product
enhancements; agreements, collaborations, & partnerships, geographic expansions;
strategic acquisitions; and others (offering research fund & grants and organizing
conferences/seminars) are the major strategies adopted by most market players to achieve
growth in the global NGS market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis
market share analysis of top players, and company profiles, which together comprise and
discuss basic views on the competitive landscape, emerging and high-growth segments of
the NGS market, high-growth regions and their respective drivers, restraints, challenges,
and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge
the pulse of the market, which in turn will help firms in garnering a greater market share.
Firms purchasing the report could use any one or combination of the below mentioned five
strategies (market penetration, product development/innovation, market development, and
competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on NGS products offered by the top 10
players in the NGS market. The report analyzes the NGS market by products & services,
technology, application, and end user
Product Development/Innovation: Detailed insights on current and upcoming technologies,
research and development activities, product enhancements, and new product launches in
the NGS market
Market Development: Comprehensive information about lucrative emerging markets. The
report analyzes the markets for various NGS devices across four geographies
Competitive Assessment: In-depth assessment of market shares, strategies, products,
distribution networks, and manufacturing capabilities of leading players in the NGS marketTable of contents:
TABLE OF CONTENTS
1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
2.1.1 SECONDARY DATA 25
2.1.1.1 Key data from secondary sources 25
2.1.2 PRIMARY DATA 25
2.1.2.1 Breakdown of primaries 26
2.1.2.2 Key data from primary sources 26
2.1.2.3 Key industry insights 27
2.2 MARKET SIZE ESTIMATION 27
2.2.1 BOTTOM-UP APPROACH 28
2.2.2 TOP-DOWN APPROACH 28
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.4 RESEARCH ASSUMPTIONS 31
3 EXECUTIVE SUMMARY 32
3.1 INTRODUCTION 32
3.2 CURRENT SCENARIO 33
3.3 FUTURE OUTLOOK 34
3.4 CONCLUSION 35
4 PREMIUM INSIGHTS 36
4.1 GLOBAL NGS MARKET (20162021) 36
4.2 GLOBAL NGS MARKET SHARE, BY PRODUCTS & SERVICES (2016 VS. 2021) 37
4.3 NGS SEQUENCING SERVICES MARKET, BY APPLICATIONS (2016 VS. 2021) 38
4.4 GLOBAL NGS TECHNOLOGY MARKET SIZE, BY REGION (2016-2021) 39
?
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 41
5.2 MARKET SEGMENTATION 41
5.2.1 BY PRODUCTS & SERVICES 41
5.2.2 BY TECHNOLOGY 42
5.2.3 BY APPLICATION 42
5.2.4 BY END USER 425.3 MARKET DYNAMICS 43
5.3.1 DRIVERS 43
5.3.1.1 Technological Advancements in Sequencing Platforms 43
5.3.1.2 Increasing Applications of NGS 44
5.3.1.3 Growing Partnerships and Collaborations 45
5.3.1.4 Research Laboratories and Academicians Promoting NGS 46
5.3.1.5 Entry of New Market Players 46
5.3.1.6 Conferences and Workshops Increasing Awareness on NGS Products and Services
47
5.3.2 RESTRAINTS 48
5.3.2.1 Accuracy & Standardization Concerns in Diagnostic Testing 48
5.3.2.2 Lack of Skilled Professionals 48
5.3.2.3 Ethical and Legal Issues Related to NGS 49
5.3.3 OPPORTUNITIES 50
5.3.3.1 Personalized Medicine & Biomarker Discovery Open Avenues for the Growth of NGS
Market 50
5.3.3.2 Emerging Markets Offer Numerous Growth Opportunities 51
5.3.3.3 Cloud Computing, a Prospective Service 51
5.3.4 CHALLENGES 52
5.3.4.1 Interpretation of Complex Data from NGS Platforms 52
5.3.4.2 Storage of Sequencing Data 52
5.3.5 CURRENT TRENDS 53
5.3.5.1 Development of New and Advanced NGS Platforms 53
5.3.5.2 Focus on Cancer Research 53
5.3.5.3 Mergers and Acquisitions 53
6 GLOBAL NGS MARKET, BY PRODUCTS & SERVICES 55
6.1 INTRODUCTION 56
6.2 PRE-SEQUENCING PRODUCTS & SERVICES 57
6.2.1 SAMPLE PREPARATION 57
6.2.1.1 DNA Fragmentation, End Repair, A-tailing, and Size Selection 58
6.2.1.2 Library Preparation & Target Enrichment 59
6.2.1.3 Quality Control 60
?
6.3 NGS PLATFORMS, CONSUMABLES, & SERVICES FOR PLATFORMS 61
6.3.1 NGS PLATFORMS MARKET 62
6.3.1.1 Illumina 63
6.3.1.1.1 HiSeq Series 64
6.3.1.1.2 HiSeq X Ten & HiSeq X Five 64
6.3.1.1.3 MiSeq Series 65
6.3.1.1.4 NextSeq500 66
6.3.1.2 Thermo Fisher Scientific (Life Technologies) 67
6.3.1.2.1 SOLiD Series 68
6.3.1.2.2 Ion Torrent Platforms 69
6.3.1.2.2.1 Ion PGM 696.3.1.2.2.2 Ion Proton 69
6.3.1.2.2.3 Ion S5 & S5 XL 70
6.3.1.3 Pacific Biosciences 71
6.3.1.3.1 PacBio RS II 72
6.3.1.3.2 Sequel System 72
6.3.1.4 Recently Launched Sequencing Platforms 73
6.4 SEQUENCING SERVICES 75
6.4.1 TARGETED RE-SEQUENCING 76
6.4.2 RNA-SEQ 77
6.4.3 DE NOVO SEQUENCING 77
6.4.4 EXOME SEQUENCING 78
6.4.5 CHIP-SEQ 79
6.4.6 WHOLE-GENOME SEQUENCING 79
6.4.7 METHYL-SEQ 80
6.4.8 OTHERS 81
6.5 NGS DATA ANALYSIS, STORAGE, AND MANAGEMENT (BIOINFORMATICS) 81
6.5.1.1 NGS Data Analysis Software & Workbenches 82
6.5.1.2 NGS Data Analysis Services 83
6.5.1.3 NGS Storage, Management, and Cloud Computing Solutions 84
7 GLOBAL NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY 85
7.1 INTRODUCTION 86
7.2 SEQUENCING BY SYNTHESIS (SBS) 87
7.3 ION SEMICONDUCTOR SEQUENCING 88
7.4 SEQUENCING BY LIGATION (SBL) 89
7.5 PYROSEQUENCING 90
7.6 SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 91
7.7 OTHER TECHNOLOGIES 92
?
8 GLOBAL NGS MARKET, BY APPLICATION 93
8.1 INTRODUCTION 94
8.2 DIAGNOSTICS 95
8.3 DRUG DISCOVERY 96
8.4 BIOMARKER DISCOVERY 97
8.5 PERSONALIZED MEDICINE 98
8.6 AGRICULTURE & ANIMAL RESEARCH 99
8.7 OTHER APPLICATIONS 100
9 NEXT-GENERATION SEQUENCING MARKET, BY END USER 102
9.1 INTRODUCTION 103
9.1.1 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 104
9.1.2 HOSPITALS & CLINICS 105
9.1.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 106
9.1.4 OTHER END-USERS (NPO, AGRIGENOMICS ORGANIZATIONS, CONSUMER
GENOMIC COMPANIES) 107
10 NEXT GENERATION SEQUENCING MARKET, BY REGION 10810.1 INTRODUCTION 109
10.2 NORTH AMERICA 110
10.2.1 U.S. 111
10.2.1.1 Favorable government funding scenario in the U.S. market 111
10.2.1.2 Growing focus of NGS market players on strengthening their presence in the U.S.
112
10.2.1.3 Increasing number of NGS conferences in the U.S. 112
10.2.1.4 Increasing focus of laboratories to obtain CLIA certification 113
10.2.2 CANADA 113
10.2.2.1 Favorable government funding scenario in Canada 113
10.2.2.2 Growing focus of market players on expanding their presence in Canada 113
10.3 EUROPE 118<